VYNE Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of VYNE Therapeutics Inc. is Fair to Shareholders

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the merger between VYNE Therapeutics Inc. and Yarrow Bioscience, Inc. for VYNE shareholders, who are expected to own approximately 3% of the combined company after the transaction [1]. Group 1 - The investigation focuses on whether VYNE and its board violated federal securities laws or breached fiduciary duties by not obtaining the best possible consideration for shareholders and failing to disclose all material information necessary for assessing the merger [3]. - Halper Sadeh LLC may seek increased consideration for VYNE shareholders, additional disclosures, and other relief related to the proposed transaction [4].